Actinobacillus pleuropneumoniae and application thereof
The invention is applicable to the technical field of molecular biology, and provides actinobacillus pleuropneumoniae and an application thereof, the actinobacillus pleuropneumoniae is named as actinobacillus pleuropneumoniae SDHG-1, and the preservation number of the actinobacillus pleuropneumoniae is CCTCC N O: M 2021204. The actinobacillus pleuropneumoniae SDHG-1 provided by the embodiment of the invention is a viscous actinobacillus pleuropneumoniae strain of serum 12 type, is rich in polysaccharide on the surface, can improve the transcriptional level of genes related to synthesis of extracellular matrix polysaccharide, is a potential polysaccharide expression system candidate strain and vaccine candidate strain, has wide application potential, and can be widely applied to the field of clinical application. The method can become one of important tools for effectively preventing and controlling porcine contagious pleuropneumonia..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Europäisches Patentamt - (2021) vom: 30. Juli Zur Gesamtaufnahme - year:2021 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
LEI LIANCHENG [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2021-07-30, Last update posted on www.tib.eu: 2022-04-11, Last updated: 2023-02-09 |
|---|
| Patentnummer: |
CN113186120 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA012205486 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA012205486 | ||
| 003 | DE-627 | ||
| 005 | 20230503171512.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230215s2021 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA012205486 | ||
| 035 | |a (EPA)CN113186120 | ||
| 035 | |a (EPA)76974461 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a LEI LIANCHENG |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Actinobacillus pleuropneumoniae and application thereof |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2021-07-30, Last update posted on www.tib.eu: 2022-04-11, Last updated: 2023-02-09 | ||
| 520 | |a The invention is applicable to the technical field of molecular biology, and provides actinobacillus pleuropneumoniae and an application thereof, the actinobacillus pleuropneumoniae is named as actinobacillus pleuropneumoniae SDHG-1, and the preservation number of the actinobacillus pleuropneumoniae is CCTCC N O: M 2021204. The actinobacillus pleuropneumoniae SDHG-1 provided by the embodiment of the invention is a viscous actinobacillus pleuropneumoniae strain of serum 12 type, is rich in polysaccharide on the surface, can improve the transcriptional level of genes related to synthesis of extracellular matrix polysaccharide, is a potential polysaccharide expression system candidate strain and vaccine candidate strain, has wide application potential, and can be widely applied to the field of clinical application. The method can become one of important tools for effectively preventing and controlling porcine contagious pleuropneumonia. | ||
| 650 | 4 | |a C12N: Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media (microbiological testing media c12q0001000000) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a C12R: Indexing scheme associated with subclasses c12c-c12q, relating to microorganisms | |
| 650 | 4 | |a C12P: Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a bio | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a LI ZIHENG |4 aut | |
| 700 | 0 | |a ZHANG XIAOGUANG |4 aut | |
| 700 | 0 | |a LI NA |4 aut | |
| 700 | 0 | |a LI FENGYANG |4 aut | |
| 700 | 0 | |a ZHU RINING |4 aut | |
| 700 | 0 | |a BAO CHUNTONG |4 aut | |
| 700 | 0 | |a SUN CHANGJIANG |4 aut | |
| 700 | 0 | |a YAN GUANGMOU |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2021) vom: 30. Juli |
| 773 | 1 | 8 | |g year:2021 |g day:30 |g month:07 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/76974461/publication/CN113186120A1?q=CN113186120 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | u | w | |j 2021 |b 30 |c 07 |
| 951 | |a AR | ||
| 952 | |j 2021 |b 30 |c 07 | ||